BioCorRx Inc.
OTC · CIK 0001443863 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$214,539
Cost Of Revenue
$25,184
Operating Income
$-956,000
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $214,539 | - | - |
| Cost Of Revenue | $25,184 | - | - |
| Operating Income | $-956,000 | - | - |
| Net Income | $-831,227 | - | - |
| Eps Diluted | -0.03 | - | - |
| Total Assets | $2.3M | - | - |
| Total Liabilities | $13.9M | - | - |
| Shareholders Equity | $-11.5M | - | - |
| Operating Cash Flow | $-432,971 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | BioCorRx Inc. | 2026-05-15 | 0001477932-26-003159 |
| 10-K | BioCorRx Inc. | 2026-03-31 | 0001477932-26-001807 |
| 10-Q | BioCorRx Inc. | 2025-11-14 | 0001477932-25-008319 |
| 10-Q | BioCorRx Inc. | 2025-08-14 | 0001477932-25-005862 |